17-47946670-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_018129.4(PNPO):c.674G>T(p.Arg225Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R225H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_018129.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pyridoxal phosphate-responsive seizures Pathogenic:2
PS1,PS3,PM3(strong),PP3,PM2,PP1 -
This variant disrupts the p.Arg225 amino acid residue in PNPO. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22858719, 24266778, 24645144, 24658933). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PNPO protein function. ClinVar contains an entry for this variant (Variation ID: 206451). This missense change has been observed in individual(s) with developmental and epileptic encephalopathy (PMID: 22858719, 28985901). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 225 of the PNPO protein (p.Arg225Leu). -
not provided Pathogenic:1
The R225L missense variant in the PNPO gene has been reported previously as a homozygous variant in two siblings with pyridox(am)ine-5'-phosphate oxidase (PNPO) deficiency (Sund et al., 2013). R225L is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution alters a highly conserved position in the predicted substrate binding region of the PNP oxidase enzyme and functional studies indicate that the R225 residue lies within a region of the protein that is necessary for substrate binding and catalysis (Musayev et al., 2009). In addition, other missense variants at the same position (R225H, R225C) have been reported previously in association with PNPO deficiency. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at